1231P Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy
Year: 2021
Type: article
Source: Annals of Oncology
Authors: J.C-H. Yang, S.S. Ramalingam, T.M. Kim, S-W. Kim, G.J. Riely, T. Mekhail, D. Nguyen, M.R. Garcia Campelo, E. Felip, L. Bazhenova, S. Jin, C. Griffin, V. Bunn, J. Lin, E.N. Churchill, M. Mehta, P.A. Janne, C. Zhou
Institutions: National Taiwan University, Emory University, Winship Cancer Institute, Seoul National University Hospital, Asan Medical Center, University of Ulsan, Memorial Sloan Kettering Cancer Center, AdventHealth Orlando, Complexo Hospitalario Universitario A Coruña, Vall d'Hebron Hospital Universitari, University of California San Diego, Moores Cancer Center, Takeda Oncology (United States), Dana-Farber Cancer Institute, Tongji University, Shanghai Pulmonary Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3203663126